BTG plc’s “Sell” Rating Reiterated at N+1 Singer (BTG)
BTG plc (LON:BTG)‘s stock had its “sell” rating restated by research analysts at N+1 Singer in a report released on Thursday. They currently have a GBX 486 ($8.04) price target on the stock. N+1 Singer’s price target points to a potential downside of 26.14% from the company’s current price.
BTG plc (LON:BTG) traded down 2.42% during mid-day trading on Thursday, hitting GBX 645.00. The stock had a trading volume of 232,691 shares. BTG plc has a 52-week low of GBX 363.00 and a 52-week high of GBX 665.00. The stock has a 50-day moving average of GBX 616.0 and a 200-day moving average of GBX 586.8. The company’s market cap is £2.328 billion.
A number of other analysts have also recently weighed in on BTG. Analysts at FinnCap reiterated a “sell” rating on shares of BTG plc in a research note on Thursday. They now have a GBX 345 ($5.71) price target on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of BTG plc in a research note on Tuesday. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of BTG plc in a research note on Tuesday, August 12th. They now have a GBX 655 ($10.84) price target on the stock. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of GBX 553.57 ($9.16).
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with Analyst Ratings Network's FREE daily email newsletter.